Prodrugs for targeting hypoxic tissues: Regiospecific elimination of aspirin from reduced indolequinones

A series of regioisomeric derivatives of a 1-methylindole-4,7-dione were synthesised, substituted with a 2-acetoxybenzoate leaving group linked through the (indol-2-yl)methyl or (indol-3-yl)methyl (or propenyl) positions. Reductive elimination of the leaving group occurred from the (indol-3-yl)methy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 1999-01, Vol.9 (1), p.113-118
Hauptverfasser: Jaffar, M, Everett, S.A, Naylor, M.A, Moore, S.G, Ulhaq, S, Patel, K.B, Stratford, M.R.L, Nolan, J, Wardman, P, Stratford, I.J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 118
container_issue 1
container_start_page 113
container_title Bioorganic & medicinal chemistry letters
container_volume 9
creator Jaffar, M
Everett, S.A
Naylor, M.A
Moore, S.G
Ulhaq, S
Patel, K.B
Stratford, M.R.L
Nolan, J
Wardman, P
Stratford, I.J
description A series of regioisomeric derivatives of a 1-methylindole-4,7-dione were synthesised, substituted with a 2-acetoxybenzoate leaving group linked through the (indol-2-yl)methyl or (indol-3-yl)methyl (or propenyl) positions. Reductive elimination of the leaving group occurred from the (indol-3-yl)methyl derivatives but not the 2-substituted regioisomers, indicating that only the C-3 position may be utilised in bioreductively-activated drug delivery, which was demonstrated with an aspirin prodrug. Graphic
doi_str_mv 10.1016/S0960-894X(98)00695-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69577831</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X98006957</els_id><sourcerecordid>69577831</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-7611ae0fb685146009ec1a07b7919adcca7320f8fb2c83f605fd85c99fb67d6d3</originalsourceid><addsrcrecordid>eNqFkF1rFTEQhoMo9Vj9CYVciOjF1qS7mw9vRIq2hULFD_Au5CST05HdZJvsSvvvm9NzaC-9Gsg878zkIeSIs2POuPj4k2nBGqW7P--1-sCY0H0jn5EV70TXtB3rn5PVI_KSvCrlL2O8Y113QA601qwTckWuv-fk87IpNKRMZ5s3MGPc0Ou7Kd2iozOWskD5RH_ABlOZwGGozzDgiNHOmCJNgdoyYcZIQ04jzeAXB55i9GmAmwVjilBekxfBDgXe7Osh-f3t66_T8-by6uzi9Mtl41ql50YKzi2wsBaqrz9hTIPjlsm11Fxb75yV7QkLKqxPnGqDYH3wqnda14T0wreH5N1u7pTTTb18NiMWB8NgI6SlmKpJStXyCvY70OVUSoZgpoyjzXeGM7M1bB4Mm60-o5V5MGxkzR3tFyzrEfxjaq-09t_u-7Y4O4Rso8PyNFyInqst9nmHQZXxDyGb4hBiFYcZ3Gx8wv8ccg93ipsO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69577831</pqid></control><display><type>article</type><title>Prodrugs for targeting hypoxic tissues: Regiospecific elimination of aspirin from reduced indolequinones</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Jaffar, M ; Everett, S.A ; Naylor, M.A ; Moore, S.G ; Ulhaq, S ; Patel, K.B ; Stratford, M.R.L ; Nolan, J ; Wardman, P ; Stratford, I.J</creator><creatorcontrib>Jaffar, M ; Everett, S.A ; Naylor, M.A ; Moore, S.G ; Ulhaq, S ; Patel, K.B ; Stratford, M.R.L ; Nolan, J ; Wardman, P ; Stratford, I.J</creatorcontrib><description>A series of regioisomeric derivatives of a 1-methylindole-4,7-dione were synthesised, substituted with a 2-acetoxybenzoate leaving group linked through the (indol-2-yl)methyl or (indol-3-yl)methyl (or propenyl) positions. Reductive elimination of the leaving group occurred from the (indol-3-yl)methyl derivatives but not the 2-substituted regioisomers, indicating that only the C-3 position may be utilised in bioreductively-activated drug delivery, which was demonstrated with an aspirin prodrug. Graphic</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/S0960-894X(98)00695-7</identifier><identifier>PMID: 9990467</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Animals ; Anti-Inflammatory Agents, Non-Steroidal ; Antineoplastic agents ; Arthritis - metabolism ; Aspirin - chemistry ; Aspirin - metabolism ; Biological and medical sciences ; Free Radicals - metabolism ; General aspects ; Humans ; Hypoxia - drug therapy ; Hypoxia - metabolism ; Indoles - chemistry ; Indoles - metabolism ; Medical sciences ; Neoplasms - metabolism ; Oxidation-Reduction ; Pharmacology. Drug treatments ; Prodrugs - chemistry ; Prodrugs - metabolism ; Quinones - chemistry ; Quinones - metabolism ; Structure-Activity Relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 1999-01, Vol.9 (1), p.113-118</ispartof><rights>1998</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-7611ae0fb685146009ec1a07b7919adcca7320f8fb2c83f605fd85c99fb67d6d3</citedby><cites>FETCH-LOGICAL-c389t-7611ae0fb685146009ec1a07b7919adcca7320f8fb2c83f605fd85c99fb67d6d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0960-894X(98)00695-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1665187$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9990467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jaffar, M</creatorcontrib><creatorcontrib>Everett, S.A</creatorcontrib><creatorcontrib>Naylor, M.A</creatorcontrib><creatorcontrib>Moore, S.G</creatorcontrib><creatorcontrib>Ulhaq, S</creatorcontrib><creatorcontrib>Patel, K.B</creatorcontrib><creatorcontrib>Stratford, M.R.L</creatorcontrib><creatorcontrib>Nolan, J</creatorcontrib><creatorcontrib>Wardman, P</creatorcontrib><creatorcontrib>Stratford, I.J</creatorcontrib><title>Prodrugs for targeting hypoxic tissues: Regiospecific elimination of aspirin from reduced indolequinones</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A series of regioisomeric derivatives of a 1-methylindole-4,7-dione were synthesised, substituted with a 2-acetoxybenzoate leaving group linked through the (indol-2-yl)methyl or (indol-3-yl)methyl (or propenyl) positions. Reductive elimination of the leaving group occurred from the (indol-3-yl)methyl derivatives but not the 2-substituted regioisomers, indicating that only the C-3 position may be utilised in bioreductively-activated drug delivery, which was demonstrated with an aspirin prodrug. Graphic</description><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal</subject><subject>Antineoplastic agents</subject><subject>Arthritis - metabolism</subject><subject>Aspirin - chemistry</subject><subject>Aspirin - metabolism</subject><subject>Biological and medical sciences</subject><subject>Free Radicals - metabolism</subject><subject>General aspects</subject><subject>Humans</subject><subject>Hypoxia - drug therapy</subject><subject>Hypoxia - metabolism</subject><subject>Indoles - chemistry</subject><subject>Indoles - metabolism</subject><subject>Medical sciences</subject><subject>Neoplasms - metabolism</subject><subject>Oxidation-Reduction</subject><subject>Pharmacology. Drug treatments</subject><subject>Prodrugs - chemistry</subject><subject>Prodrugs - metabolism</subject><subject>Quinones - chemistry</subject><subject>Quinones - metabolism</subject><subject>Structure-Activity Relationship</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1rFTEQhoMo9Vj9CYVciOjF1qS7mw9vRIq2hULFD_Au5CST05HdZJvsSvvvm9NzaC-9Gsg878zkIeSIs2POuPj4k2nBGqW7P--1-sCY0H0jn5EV70TXtB3rn5PVI_KSvCrlL2O8Y113QA601qwTckWuv-fk87IpNKRMZ5s3MGPc0Ou7Kd2iozOWskD5RH_ABlOZwGGozzDgiNHOmCJNgdoyYcZIQ04jzeAXB55i9GmAmwVjilBekxfBDgXe7Osh-f3t66_T8-by6uzi9Mtl41ql50YKzi2wsBaqrz9hTIPjlsm11Fxb75yV7QkLKqxPnGqDYH3wqnda14T0wreH5N1u7pTTTb18NiMWB8NgI6SlmKpJStXyCvY70OVUSoZgpoyjzXeGM7M1bB4Mm60-o5V5MGxkzR3tFyzrEfxjaq-09t_u-7Y4O4Rso8PyNFyInqst9nmHQZXxDyGb4hBiFYcZ3Gx8wv8ccg93ipsO</recordid><startdate>19990104</startdate><enddate>19990104</enddate><creator>Jaffar, M</creator><creator>Everett, S.A</creator><creator>Naylor, M.A</creator><creator>Moore, S.G</creator><creator>Ulhaq, S</creator><creator>Patel, K.B</creator><creator>Stratford, M.R.L</creator><creator>Nolan, J</creator><creator>Wardman, P</creator><creator>Stratford, I.J</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990104</creationdate><title>Prodrugs for targeting hypoxic tissues: Regiospecific elimination of aspirin from reduced indolequinones</title><author>Jaffar, M ; Everett, S.A ; Naylor, M.A ; Moore, S.G ; Ulhaq, S ; Patel, K.B ; Stratford, M.R.L ; Nolan, J ; Wardman, P ; Stratford, I.J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-7611ae0fb685146009ec1a07b7919adcca7320f8fb2c83f605fd85c99fb67d6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal</topic><topic>Antineoplastic agents</topic><topic>Arthritis - metabolism</topic><topic>Aspirin - chemistry</topic><topic>Aspirin - metabolism</topic><topic>Biological and medical sciences</topic><topic>Free Radicals - metabolism</topic><topic>General aspects</topic><topic>Humans</topic><topic>Hypoxia - drug therapy</topic><topic>Hypoxia - metabolism</topic><topic>Indoles - chemistry</topic><topic>Indoles - metabolism</topic><topic>Medical sciences</topic><topic>Neoplasms - metabolism</topic><topic>Oxidation-Reduction</topic><topic>Pharmacology. Drug treatments</topic><topic>Prodrugs - chemistry</topic><topic>Prodrugs - metabolism</topic><topic>Quinones - chemistry</topic><topic>Quinones - metabolism</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jaffar, M</creatorcontrib><creatorcontrib>Everett, S.A</creatorcontrib><creatorcontrib>Naylor, M.A</creatorcontrib><creatorcontrib>Moore, S.G</creatorcontrib><creatorcontrib>Ulhaq, S</creatorcontrib><creatorcontrib>Patel, K.B</creatorcontrib><creatorcontrib>Stratford, M.R.L</creatorcontrib><creatorcontrib>Nolan, J</creatorcontrib><creatorcontrib>Wardman, P</creatorcontrib><creatorcontrib>Stratford, I.J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jaffar, M</au><au>Everett, S.A</au><au>Naylor, M.A</au><au>Moore, S.G</au><au>Ulhaq, S</au><au>Patel, K.B</au><au>Stratford, M.R.L</au><au>Nolan, J</au><au>Wardman, P</au><au>Stratford, I.J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prodrugs for targeting hypoxic tissues: Regiospecific elimination of aspirin from reduced indolequinones</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>1999-01-04</date><risdate>1999</risdate><volume>9</volume><issue>1</issue><spage>113</spage><epage>118</epage><pages>113-118</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A series of regioisomeric derivatives of a 1-methylindole-4,7-dione were synthesised, substituted with a 2-acetoxybenzoate leaving group linked through the (indol-2-yl)methyl or (indol-3-yl)methyl (or propenyl) positions. Reductive elimination of the leaving group occurred from the (indol-3-yl)methyl derivatives but not the 2-substituted regioisomers, indicating that only the C-3 position may be utilised in bioreductively-activated drug delivery, which was demonstrated with an aspirin prodrug. Graphic</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>9990467</pmid><doi>10.1016/S0960-894X(98)00695-7</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 1999-01, Vol.9 (1), p.113-118
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_69577831
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Anti-Inflammatory Agents, Non-Steroidal
Antineoplastic agents
Arthritis - metabolism
Aspirin - chemistry
Aspirin - metabolism
Biological and medical sciences
Free Radicals - metabolism
General aspects
Humans
Hypoxia - drug therapy
Hypoxia - metabolism
Indoles - chemistry
Indoles - metabolism
Medical sciences
Neoplasms - metabolism
Oxidation-Reduction
Pharmacology. Drug treatments
Prodrugs - chemistry
Prodrugs - metabolism
Quinones - chemistry
Quinones - metabolism
Structure-Activity Relationship
title Prodrugs for targeting hypoxic tissues: Regiospecific elimination of aspirin from reduced indolequinones
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T13%3A56%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prodrugs%20for%20targeting%20hypoxic%20tissues:%20Regiospecific%20elimination%20of%20aspirin%20from%20reduced%20indolequinones&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Jaffar,%20M&rft.date=1999-01-04&rft.volume=9&rft.issue=1&rft.spage=113&rft.epage=118&rft.pages=113-118&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/S0960-894X(98)00695-7&rft_dat=%3Cproquest_cross%3E69577831%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69577831&rft_id=info:pmid/9990467&rft_els_id=S0960894X98006957&rfr_iscdi=true